Literature DB >> 14560405

A two-stage approach to primary knee arthroplasty in the infected arthritic knee.

David G Nazarian1, Dino de Jesus, Francis McGuigan, Robert E Booth.   

Abstract

Fourteen patients with either septic knee arthritis or osteomyelitis of the knee with marked joint destruction were treated by resection arthroplasty with the introduction of an antibiotic cement spacer block, appropriate antibiotic therapy, and subsequent primary total knee arthroplasty. Most patients with septic arthritis had chronic infection. Eight patients had positive cultures preoperatively; the remaining patients had either a culture negative purulent aspiration or diagnostic radiographic studies. All patients underwent reconstruction with primary total knee arthroplasty on an average of 3.1 months after the initial stage procedure. Knee Society scores progressed from 46 preoperatively to 89 postoperatively, with an average range of motion from 3 degrees to 105 degrees. At latest clinical follow-up (average, 4.5 years), no patients had recurrence of infection. These data suggest that this method is successful in treating chronically infected knees with a 2-staged arthroplasty.

Entities:  

Mesh:

Year:  2003        PMID: 14560405     DOI: 10.1016/s0883-5403(03)00343-7

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  20 in total

1.  Short-interval two-stage approach to primary total knee arthroplasty for acutely septic osteoarthritic knees.

Authors:  Bettina Hochreiter; Carol Strahm; Henrik Behrend
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-01-14       Impact factor: 4.342

2.  CORR Insights®: Patients with a History of Treated Septic Arthritis are at High Risk of Periprosthetic Joint Infection after Total Joint Arthroplasty.

Authors:  Hari P Bezwada
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

Review 3.  Bilateral knee replacements for treatment of acute septic arthritis in both knees.

Authors:  Muhammad Omer Ashraf; Theophilus Asumu
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-04

Review 4.  Two-stage approach to total knee arthroplasty using colistin-loaded articulating cement spacer for vancomycin-resistant Pseudomonas aeruginosa infection in an arthritic knee.

Authors:  Moon Jong Chang; Min Kyu Song; Jae Hoon Shin; Chan Yoon; Chong Bum Chang; Seung-Baik Kang
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-06-18

5.  Patients with a History of Treated Septic Arthritis are at High Risk of Periprosthetic Joint Infection after Total Joint Arthroplasty.

Authors:  Assem A Sultan; Bilal Mahmood; Linsen T Samuel; Jaiben George; Mhamad Faour; Christopher E Pelt; Mike B Anderson; Alison K Klika; Carlos A Higuera
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

6.  Successful two-stage primary total knee arthroplasty for infective arthritis of the knee - our experience.

Authors:  Sam Supreeth; Suwailim Al Ghanami; Saseendar Shanmugasundaram; Raad Sabri Al Rawi; Ali Redha Abdawani; Shenouda R Abdelmasih
Journal:  J Clin Orthop Trauma       Date:  2020-07-04

Review 7.  [Acute joint infection--diagnosis and treatment].

Authors:  J Jerosch
Journal:  Orthopade       Date:  2004-11       Impact factor: 1.087

8.  Two-stage approach to primary TKA in infected arthritic knees using intraoperatively molded articulating cement spacers.

Authors:  Aseem Arif Shaikh; Chul-Won Ha; Yong-Geun Park; Yong-Beom Park
Journal:  Clin Orthop Relat Res       Date:  2014-03-06       Impact factor: 4.176

9.  Prosthetic knee infection by resistant bacteria: the worst-case scenario.

Authors:  Michele Vasso; Alfredo Schiavone Panni; Ivan De Martino; Giorgio Gasparini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-02-01       Impact factor: 4.342

10.  An aluminium mold for intraoperative production of antibiotic-loaded PMMA knee prostheses.

Authors:  Sandro Kohl; Andreas Krueger; Christoph Roeder; Maximilian Hartel; Hendrik Kohlhof; Claudia Schneider; Stefan Eggli
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.